Me’s debacle should be a major wake-up call, reminding policymakers and all of us of the risks of giving access to our ...

Pulmonologists share best practices on when primary care providers should consider sending patients with respiratory ...

Researchers from GlaxoSmithKline have reported that a single dose of the RSV vaccine, Arexvy (RSVPreF3 OA), provides ...

Pharmaceutical bosses and the government are racing to stop Donald Trump slapping tariffs on medicines in a move that would ...

Arrowhead Pharmaceuticals, Inc.’s ARWR share price has dipped by 10.49%, which has investors questioning if this is right ...

London: British pharmaceutical major GlaxoSmithKline (GSK) has failed to meet the required regulatory and ethical standards ...

As measles makes a comeback in the US, Indian health experts urge vigilance. With over 7,000 cases reported recently, should ...

GlaxoSmithKline recently held a high-level scientific conference in conjunction with the launch of “Bexsero,” the first ...

In a report released today, Emily Field from Barclays maintained a Hold rating on GlaxoSmithKline (GSK – Research Report), with a price target ...

Coherus BioSciences, Inc.’s CHRS share price has dipped by 5.19%, which has investors questioning if this is right time to ...

The market is characterized by trends such as personalized medicine, targeted therapies, and combination treatments. Key players include Eli Lilly, Bristol Myers Squibb, and AstraZeneca. As North ...